Results 81 to 90 of about 23,589 (259)
Synthesis of Triazoloquinoxalines as Antitubercular Agents [PDF]
1,2,4-Triazoles and quinoxalines were found to display various pharmacological activities. Hence a series of 1-aryl-4-methyl-1,2,4-triazolo[4,3-a]quinoxalines were synthesized. Due to various advantages of organic reactions under solvent-free conditions these compounds were developed using iodobenzene diacetate under solvent-free conditions.
Kondapalli Venkata Gowri Chandra Sekhar +2 more
openaire +1 more source
Two novel carboxamide hydrazone hybrids are synthesized and characterized. Structural, spectroscopic, and computational analyses reveal dominant hydrogen bonding, π–π stacking, and reactive sites. Compound 2b exhibits potent antibacterial activity against Staphylococcus aureus, highlighting its potential as a cost‐effective therapeutic agent.
Nabila A. Kheder +6 more
wiley +1 more source
MEPicides: Potent antimalarial prodrugs targeting isoprenoid biosynthesis [PDF]
The emergence of Plasmodium falciparum resistant to frontline therapeutics has prompted efforts to identify and validate agents with novel mechanisms of action. MEPicides represent a new class of antimalarials that inhibit enzymes of the methylerythritol
Brothers, Robert C +10 more
core +2 more sources
Advancing Tuberculosis Chemotherapy: Targeted Nanomedicines for the Mycobacterium TB Granuloma
This graphical abstract illustrates nanosystems used for targeted drug delivery into tuberculosis granulomas. It shows how targeting is influenced by size, pH, redox sensitivity, and surface charge. Various nanoparticles are incorporated with drugs to enhance penetration, stability, and release.
Shreya Ranjith Singh +3 more
wiley +1 more source
_M. tuberculosis_ interactome analysis unravels potential pathways to drug resistance [PDF]
Drug resistance is a major problem for combating tuberculosis. Lack of understanding of how resistance emerges in bacteria upon drug treatment limits our ability to counter resistance.
Karthik Raman, Nagasuma Chandra
core +1 more source
MmpL3 is the flippase for mycolic acids in mycobacteria [PDF]
The defining feature of the mycobacterial outer membrane (OM) is the presence of mycolic acids (MAs), which, in part, render the bilayer extremely hydrophobic and impermeable to external insults, including many antibiotics.
Chng, Shu-Sin +3 more
core +1 more source
Aims Bedaquiline (BDQ) is a first‐in‐class diarylquinoline (DARQ) and a potent anti‐tuberculosis drug, vital in combating multi‐drug resistant tuberculosis (TB). Understanding its lung pharmacokinetics (PK) across species is crucial for effective clinical translation.
Evangelos Karakitsios +2 more
wiley +1 more source
Clinical research progress of tuberculous meningitis
Tuberculous meningitis is an infectious disease of central nervous system caused by Mycobacterium tuberculosis. It mainly invades into brain meninges and parenchyma, and may spread to the spinal cord and spinal meninges.
Zhan-yun MA, Peng CHEN, Xue-wen FAN
doaj
Experimental pharmacological research regarding some new quinazolin-4-ones derivatives [PDF]
A series of new compounds with quinazolin-4-one structure, synthesized by the Pharmaceutical Chemistry Department of the Faculty of Pharmacy of the University of Medicine and Pharmacy “Carol Davila” Bucharest, was studied.
Bratu, Mihaela +8 more
core +1 more source
ABSTRACT Poncet's disease is a rare, non‐destructive reactive arthritis that occurs in the presence of active tuberculosis (TB) without direct joint infection. It is often underrecognized in TB‐endemic regions due to its clinical overlap with septic or autoimmune arthritis.
Kanza Farhan +5 more
wiley +1 more source

